Connect your AI

CareDx CDNA Increase (decrease) in contract liabilities and current deferred income

Discontinued — last reported Q3 '24

Increase (decrease) in contract liabilities and current deferred income at other companies

SPS CommerceSPSC

$4.87M+54.2%

AvePoint, Inc.AVPT

$4.39M+4.3%

AMN HealthcareAMN

-$4.41M-312%

Q2 HoldingsQTWO

$45.49M+26.0%

Rackspace Technology, Inc.RXT

$35.6M+483%

CalixCALX

$675K-80.6%

Segments

By product

Testing services revenue-$3.4M-289%

Other financials

Income statement

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

Market cap$1.4B+35.7%

Enterprise value$1.35B+38.3%

P/S3.4×+0.4×

Profitability

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.

The official record: CareDx’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about CareDx's increase (decrease) in contract liabilities and current deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CareDx's increase (decrease) in contract liabilities and current deferred income?: CareDx (CDNA) reported increase (decrease) in contract liabilities and current deferred income of $0 in Q3 2024.